Clinical Trials Browser

Phase 1/2 × NIH × Epstein-Barr Virus Infections × Clear all

NCT05683834 2025-11-21

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Phase 1/2 Active not recruiting

Herpes Simplex, Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT02496676 2022-03-02

Magnesium Supplementation in People With XMEN Syndrome

Phase 1/2 Completed

8 enrolled 7 charts

Primary Immunodeficiency Diseases, Infections, Neoplasms, Epstein-Barr Virus Infections